VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Verisk Analytics, Inc. vs West Pharmaceutical Services, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Verisk Analytics, Inc.
VRSK · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Verisk Analytics, Inc.'s moat claims, evidence, and risks.
View VRSK analysisWest Pharmaceutical Services, Inc.
WST · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into West Pharmaceutical Services, Inc.'s moat claims, evidence, and risks.
View WST analysisComparison highlights
- Moat score gap: Verisk Analytics, Inc. leads (87 / 100 vs 85 / 100 for West Pharmaceutical Services, Inc.).
- Segment focus: Verisk Analytics, Inc. has 2 segments (70.2% in Underwriting Solutions); West Pharmaceutical Services, Inc. has 2 segments (80.7% in Proprietary Products).
- Primary market structure: Oligopoly vs Quasi-Monopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Verisk Analytics, Inc. has 6 moat types across 3 domains; West Pharmaceutical Services, Inc. has 5 across 3.
Primary market context
Verisk Analytics, Inc.
Underwriting Solutions
Property and casualty insurance underwriting content and analytics (forms and rules and loss costs, underwriting data and catastrophe and weather risk)
Primarily U.S. (with growing international offerings)
P&C insurers (personal and commercial lines)
Insurance data and analytics and standards and content provider
70.2%
West Pharmaceutical Services, Inc.
Proprietary Products
Injectable primary packaging components and containment/delivery systems (elastomeric stoppers, seals, plungers, syringe/cartridge components; related services)
Global
Biologic, generic, and pharmaceutical drug manufacturers
Primary packaging and delivery component supplier
80.7%
Side-by-side metrics
Moat coverage
Shared moat types
Verisk Analytics, Inc. strengths
West Pharmaceutical Services, Inc. strengths
Segment mix
Verisk Analytics, Inc. segments
Full profile >Underwriting Solutions
Oligopoly
Claims Solutions
Oligopoly
West Pharmaceutical Services, Inc. segments
Full profile >Proprietary Products
Quasi-Monopoly
Contract-Manufactured Products
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.